BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10864491)

  • 1. Reduction in the level of cardiac cyclic GMP worsens contractile delay in myocardial stunning.
    Patel KN; Weiss HR; Scholz PM
    J Surg Res; 2000 Jul; 92(1):114-9. PubMed ID: 10864491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide reverses the negative functional effects of stunning in rabbit myocardium.
    Moalem J; Davidov T; Katz E; Scholz PM; Weiss HR
    Regul Pept; 2005 Dec; 132(1-3):47-52. PubMed ID: 16223535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide reverses the effects of myocardial stunning in rabbit myocardium.
    Anyadike C; Scholz PM; Zhang Q; Katz E; Weiss HR
    Pharmacology; 2007; 80(1):40-8. PubMed ID: 17519532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
    Davidov T; Weiss HR; Tse J; Scholz PM
    Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases in myocardial cyclic GMP attenuate contractile delay in myocardial stunning.
    Huang MW; Scholz PM; Weiss HR
    Can J Physiol Pharmacol; 2002 Aug; 80(8):804-10. PubMed ID: 12269791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative effect of nitric oxide on shortening-frequency relationship in cardiac myocytes is diminished after simulated ischemia-reperfusion.
    Weiss HR; Gandhi A; Scholz PM
    Basic Res Cardiol; 2003 Sep; 98(5):311-8. PubMed ID: 12955404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol-induced reduction in myocardial oxygen consumption can be attenuated by inhibiting guanylyl cyclase.
    Lazar MJ; Patel K; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):512-9. PubMed ID: 11588521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy.
    Straznicka M; Leone RJ; Scholz PM; Weiss HR
    J Surg Res; 1998 Apr; 76(1):61-6. PubMed ID: 9695741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
    Rabindranauth P; Naim KL; Scholz PM; Tse J; Sadoff JD; Weiss HR
    Basic Res Cardiol; 1997 Feb; 92(1):8-16. PubMed ID: 9062647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pacing-induced cardiac failure of hypertrophic hearts: effects of cyclic GMP reduction.
    Huang MW; Weiss HR; Tse J; Leone RJ; Scholz PM
    J Surg Res; 1999 Sep; 86(1):89-96. PubMed ID: 10452873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary blood flow autoregulation and flow heterogeneity in the stunned heart.
    Shnier CB; Cason BA; Horton AF; Hickey RF
    Jpn Heart J; 1994 Sep; 35(5):654-60. PubMed ID: 7830329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
    Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
    Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
    Brock SC; Tonussi CR
    Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative metabolic and coronary flow effects of decreases in cAMP and increases in cGMP in control and renal hypertensive rabbit hearts.
    Rodriguez R; Molino B; Weiss HR; Scholz PM
    J Appl Physiol (1985); 2004 Jul; 97(1):439-45. PubMed ID: 14990553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid ventricular pacing induces delayed cardioprotection against myocardial stunning.
    Lucats L; Chalvignac V; Bizé A; Monnet X; Zini R; Hittinger L; Berdeaux A; Ghaleh B
    J Mol Cell Cardiol; 2005 Dec; 39(6):849-55. PubMed ID: 16242141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
    Itoh T; Haruna M; Abe K
    Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
    Gandhi A; Yan L; Scholz PM; Huang MW; Weiss HR
    Nitric Oxide; 1999 Dec; 3(6):473-80. PubMed ID: 10637126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.